Rodrigo Andrade Schuch
Papers
3
Total Citations
155
H-Index
3
About
Rodrigo Andrade Schuch is a leading researcher in clinical proteomics and mass spectrometry, with a primary focus on developing rapid, high-throughput diagnostic tools for infectious diseases. His most impactful work centers on the COVID-19 pandemic, where he pioneered a mass spectrometry-based system for detecting SARS-CoV-2 nucleoprotein in large clinical sample cohorts. This innovative approach, detailed in his highly cited 2020 paper (126 citations), demonstrated the feasibility of using targeted proteomics for population-scale testing, offering a fast and low-cost alternative to traditional PCR methods. Schuch’s contributions extend to refining tandem mass spectrometry techniques for SARS-CoV-2 peptide detection, further enhancing the accessibility and speed of viral diagnostics. His work has been instrumental in bridging the gap between advanced proteomic technologies and real-world public health needs, particularly during global health emergencies. By enabling rapid, scalable, and cost-effective testing, Schuch has significantly advanced the field of clinical mass spectrometry, providing a critical tool for pandemic response and setting a precedent for future infectious disease surveillance.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3